Opportunities and Challenges for Environmental Exposure Assessment in Population-Based Studies
Chirag J Patel1, Jacqueline Kerr2, Duncan C Thomas3
1Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts. Christopher.I.Amos@dartmouth.edu chirag_patel@hms.harvard.edu.
Summary
New high-dimensional exposure assessments offer opportunities for cancer development research. However, analyzing extensive, correlated data presents challenges in identifying specific environmental risk factors.
Area of Science:
- Epidemiology
- Biomarkers
- Environmental Health
Background:
- Epidemiological studies increasingly utilize diverse exposure and behavior indicators, offering new research avenues but posing analytical challenges.
- Traditional study designs like case-control are limited in characterizing complex environmental exposures and their impact on disease.
Purpose of the Study:
- To evaluate epidemiological study designs for heterogeneous exposures and behaviors.
- To assess methods for capturing exposure indicators.
- To examine analytical approaches for discovery and validation in environmental health research.
Main Methods:
- Review of epidemiological study designs (case-control, prospective, two-phase).
- Discussion of innovative exposure assessment methods (microbiome, metabolomics, sensors, pollution monitoring).
- Evaluation of analytical challenges with high-dimensional, correlated exposure data.
Main Results:
- Case-control studies are insufficient for complex environmental factor analysis.
- Prospective and two-phase designs require balancing data collection with participant follow-up.
- High-dimensional exposure data presents challenges in isolating specific risk factors.
Conclusions:
- New high-dimensional exposure assessments provide significant opportunities for cancer development research.
- Advanced analytical methods are crucial for disentangling complex environmental exposures and validating findings.
- Integrating diverse data sources is key to advancing environmental exposure assessment in epidemiology.
More Related Videos
Related Concept Videos
01:25Strategies for Assessing and Addressing Confounding
483
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
483
01:27Confounding in Epidemiological Studies
892
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
892
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
01:12Analysis of Population Pharmacokinetic Data
854
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
854
01:36Types of Toxins
3.9K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.9K
01:23Toxicity Testing in Animals
63
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
63